Overview

Evaluation of PK and Safety of D-0120 and Allopurinol

Status:
Active, not recruiting
Trial end date:
2022-04-23
Target enrollment:
Participant gender:
Summary
Evaluation of safety and PK interaction between D-0120 and Alopurinol in healthy adult subjects
Phase:
Early Phase 1
Details
Lead Sponsor:
InventisBio Co., Ltd
Treatments:
Allopurinol